Who Owns Immunovant Stock?
NASDAQ: IMVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 52.79%
- Institutions (% of float)
- 119.72%
- Held by insiders
- 55.90%
- Institutional holders
- 318
- Institutions 44.1%
- Insiders 55.9%
- Public and other 0.0%
Who owns Immunovant stock?
Institutional investors own about 52.8% of Immunovant's shares, spread across 318 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 55.90% of IMVT.
The largest institutional holders are FMR, LLC (7.59%), Deep Track Capital, Lp (4.43%) and Blackrock Inc. (3.59%). Together, the top 10 institutions control 31.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their IMVT positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IMVT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 15.70M | 7.59% | -3.0% |
| Deep Track Capital, Lp | 9.16M | 4.43% | -1.9% |
| Blackrock Inc. | 7.43M | 3.59% | +3.4% |
| Farallon Capital Management LLC | 6.47M | 3.13% | +11.5% |
| Morgan Stanley | 5.68M | 2.75% | +25.4% |
| Two Seas Capital Lp | 4.61M | 2.23% | +46.5% |
| TCG Crossover Management, LLC | 4.46M | 2.15% | 0.0% |
| Vanguard Portfolio Management LLC | 4.26M | 2.06% | +9.1% |
| State Street Corporation | 4.20M | 2.03% | -9.1% |
| Vanguard Capital Management LLC | 4.09M | 1.98% | +12.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IMVT
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 5.09M | 2.46% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.60M | 1.26% |
| iShares Trust-iShares Russell 2000 ETF | 2.25M | 1.09% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.11M | 1.02% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.88M | 0.91% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 1.41M | 0.68% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.09M | 0.52% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 1.05M | 0.51% |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 991.47K | 0.48% |
| Prudential Jennison Small Co Fd., Inc.-PGIM JENNISON SMALL COMPANY Fd. | 981.54K | 0.47% |
Frequently asked questions
Who is the largest shareholder of Immunovant?
FMR, LLC is the largest institutional shareholder of IMVT, owning 7.59% of shares outstanding (15.70M shares) as of its latest 13F filing.
What percentage of Immunovant is owned by institutions?
Institutions own about 52.8% of IMVT shares and 119.7% of the public float.
How much of Immunovant do insiders own?
Insiders, such as officers and directors, own about 55.90% of IMVT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.